NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of iRhythm Technologies, Inc. (NASDAQ: IRTC) resulting from allegations that iRhythm may have issued materially misleading business information to the investing public.
Between March 13, 2019 and March 27, 2019, various analysts and reports raised questions concerning: (1) the sustainability of third-party reimbursements to iRhythm attributable to sales of its Zio XT Extended Holter patch device; (2) whether iRhythm’s statements about the total addressable market for iRhythm products may have been misleading; and (3) whether iRhythm employed misleading accounting techniques to stretch revenue and manage bad debt expense.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by iRhythm investors. If you purchased shares of iRhythm, please visit the firm’s website at https://www.rosenlegal.com/cases-register-1539.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827